Pharmacovigilance & Clinical Trials

Pharmacovigilance & Clinical Trials

The Pharmacovigilance & Clinical Trials track focuses on ensuring patient safety through comprehensive monitoring, detection, assessment, and prevention of adverse events throughout the clinical research lifecycle. This track highlights the integration of pharmacovigilance systems within clinical trials to identify safety signals early, evaluate benefit–risk profiles, and maintain regulatory compliance. Sessions will explore adverse event reporting processes, safety data management, signal detection methodologies, and the role of Data Safety Monitoring Boards (DSMBs) in protecting participant welfare. Emphasis will be placed on proactive risk management strategies and alignment with global regulatory requirements. In addition, the track addresses post-marketing surveillance, real-world safety data integration, and the use of advanced analytics and artificial intelligence to enhance signal detection and risk assessment.

  • Real-World Evidence (RWE) and Post-Marketing Safety Surveillance
  • Innovations in Clinical Trial Design and Safety Monitoring

Related Sessions

Tags